Finanzwire Finanzwire
Basculer en Français
10097 Companies
206739 Keywords
136880 Articles
109566 Press releases
Headlines Articles Press releases DEBRA Research GmbH Remove
  1. Home
  2. Companies
  3. DEBRA Research GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/29/2025 at 10:05, 10 months 27 days ago

    DEBRA Research Invests in Nova Anchora for Advancing Epidermolysis Bullosa Therapy

    Investment Epidermolysis Bullosa DEBRA Research Nova Anchora Protein Therapy
  • PRESS RELEASE

    published on 04/29/2025 at 10:00, 10 months 27 days ago

    DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa

    DEBRA Research announces impact investment into Nova Anchora to advance protein therapy for Epidermolysis Bullosa. Global investors support development of NvA-011 for rare skin disorder treatment
    Impact Investment Epidermolysis Bullosa DEBRA Research Nova Anchora Protein Therapy
    Logo of DEBRA Research GmbH
  • BRIEF

    published on 02/05/2025 at 09:05, 1 year 1 month ago

    DEBRA Research and LEO Pharma Form Strategic Partnership for Rare Skin Diseases

    Strategic Partnership Innovative Therapies Epidermolysis Bullosa Rare Skin Diseases Medical Dermatology
  • PRESS RELEASE

    published on 02/05/2025 at 09:00, 1 year 1 month ago

    DEBRA Research and LEO Pharma Announce Strategic Partnership to Advance Treatments for Rare Skin Diseases

    DEBRA Research and LEO Pharma announce strategic partnership to enhance treatments for Epidermolysis Bullosa (EB), a rare skin disease with no approved treatment options
    Strategic Partnership Epidermolysis Bullosa DEBRA Research LEO Pharma Skin Disease
    Logo of DEBRA Research GmbH
Previous page
1 2
Accesswire
  • Published on 03/26/2026 at 13:00, 15 minutes ago

    Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor

  • Published on 03/26/2026 at 13:00, 15 minutes ago

    GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle

  • Published on 03/26/2026 at 12:59, 16 minutes ago

    Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance

  • Published on 03/26/2026 at 12:45, 30 minutes ago

    Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia

  • Published on 03/26/2026 at 12:45, 30 minutes ago

    Electric Royalties Provides Update on Critical Metals Royalty Portfolio

View all ACCESSWIRE
EQS Group
  • Published on 03/26/2026 at 13:00, 15 minutes ago

    AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025

  • Published on 03/26/2026 at 13:00, 15 minutes ago

    Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI

  • Published on 03/26/2026 at 12:45, 30 minutes ago

    Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy

  • Published on 03/26/2026 at 12:20, 55 minutes ago

    North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million

  • Published on 03/26/2026 at 12:17, 58 minutes ago

    Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

View all EQS
Les Echos
  • Published on 03/26/2026 at 08:57, 4 hours 18 minutes ago

    Edenred statement

  • Published on 03/26/2026 at 07:30, 5 hours 45 minutes ago

    BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY

  • Published on 03/25/2026 at 18:53, 18 hours 22 minutes ago

    LNA SANTE : 2025 Annual Results

  • Published on 03/25/2026 at 18:31, 18 hours 44 minutes ago

    Strong investment performance and active roll-out of our strategy

  • Published on 03/25/2026 at 17:45, 19 hours 30 minutes ago

    Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy